Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000516522 | SCV000614526 | uncertain significance | not specified | 2016-09-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002525061 | SCV003631583 | uncertain significance | Inborn genetic diseases | 2023-01-31 | criteria provided, single submitter | clinical testing | The c.7169_7171delAGG (p.E2390del) alteration, located in coding exon 17 of the PKD1 gene, results from an in-frame deletion of 3 nucleotides at positions c.7169 to c.7171. This results in the deletion of a glutamic acid residue at codon 2390. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is not well conserved in available vertebrate species. This alteration is predicted to be deleterious by in silico analysis (Choi, 2012). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |